Skip to content

1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide

C22H32IN5O3 — CID 111869061

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide
SMILESCn1cc(C/N=C(\NCCCOCC2CC2)Nc2ccc3c(c2)OCCCO3)cn1.I
InChIInChI=1S/C22H31N5O3.HI/c1-27-15-18(14-25-27)13-24-22(23-8-2-9-28-16-17-4-5-17)26-19-6-7-20-21(12-19)30-11-3-10-29-20;/h6-7,12,14-15,17H,2-5,8-11,13,16H2,1H3,(H2,23,24,26);1H
InChIKeyZUEXXZDVIMTWPQ-UHFFFAOYSA-N
MW541.43 g/mol
LogP3.57
Rot. Bonds9

About 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide

1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide (PubChem CID 111869061) has the molecular formula C22H32IN5O3 and a molecular weight of 541.43 g/mol. Its IUPAC name is 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide.

Molecular Properties

Compound Name1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide
PubChem CID111869061
Molecular FormulaC22H32IN5O3
Molecular Weight541.43 g/mol
Exact Mass541.15
IUPAC Name1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide
SMILESCn1cc(C/N=C(\NCCCOCC2CC2)Nc2ccc3c(c2)OCCCO3)cn1.I
InChIInChI=1S/C22H31N5O3.HI/c1-27-15-18(14-25-27)13-24-22(23-8-2-9-28-16-17-4-5-17)26-19-6-7-20-21(12-19)30-11-3-10-29-20;/h6-7,12,14-15,17H,2-5,8-11,13,16H2,1H3,(H2,23,24,26);1H
InChIKeyZUEXXZDVIMTWPQ-UHFFFAOYSA-N
XLogP3.57
TPSA81.93 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms31
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500541.43
LogP ≤ 53.57
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide?
The IUPAC name of 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide (CID 111869061) is 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide.
What is the SMILES notation for 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide?
The canonical SMILES for 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide is Cn1cc(C/N=C(\NCCCOCC2CC2)Nc2ccc3c(c2)OCCCO3)cn1.I.
What is the InChIKey of 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide?
The InChIKey is ZUEXXZDVIMTWPQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H31N5O3.HI/c1-27-15-18(14-25-27)13-24-22(23-8-2-9-28-16-17-4-5-17)26-19-6-7-20-21(12-19)30-11-3-10-29-20;/h6-7,12,14-15,17H,2-5,8-11,13,16H2,1H3,(H2,23,24,26);1H.
What are the key properties of 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide?
1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide has a molecular weight of 541.43 g/mol, XLogP of 3.57, 9 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-(cyclopropylmethoxy)propyl]-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[(1-methylpyrazol-4-yl)methyl]guanidine;hydroiodide is sourced from PubChem (CID 111869061), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.